Cytokinetics, Inc. (CYTK)

62.95 +0.45 (+0.72%) USD  |  NASDAQ  |  Mar 30, 16:00
62.95 0.00 (0.00%) After-Hours: 16:35
More

Cytokinetics Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for CYTK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
Bristol Myers Squibb Co. Upgrade
Lifecore Biomedical, Inc. Upgrade
AtriCure, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade